Pre-existing and post-COVID-19 immune responses to SARS-CoV-2 in cancer patients
Cancer patients, in particular patients with hematological malignancies, are at increased risk for critical illness upon COVID-19. We here assessed antibody as well as CD4 and CD8 T cell responses...
researchsquare.com